Skip to main content
Erschienen in: Abdominal Radiology 1/2017

17.09.2016

Imaging of autoimmune biliary disease

verfasst von: Melinda J. Yeh, So Yeon Kim, Kartik S. Jhaveri, Spencer C. Behr, Nieun Seo, Benjamin M. Yeh

Erschienen in: Abdominal Radiology | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Autoimmune biliary diseases are poorly understood but important to recognize. Initially, autoimmune biliary diseases are asymptomatic but may lead to progressive cholestasis with associated ductopenia, portal hypertension, cirrhosis, and eventually liver failure. The three main forms of autoimmune biliary disease are primary biliary cirrhosis, primary sclerosing cholangitis, and IgG4-associated cholangitis. Although some overlap may occur between the three main autoimmune diseases of the bile ducts, each disease typically affects a distinct demographic group and requires a disease-specific diagnostic workup. For all the autoimmune biliary diseases, imaging provides a means to monitor disease progression, assess for complications, and screen for the development of hepatobiliary malignancies that are known to affect patients with these diseases. Imaging is also useful to suggest or corroborate the diagnosis of primary sclerosing cholangitis and IgG4-associated cholangitis. We review the current literature and emphasize radiological findings and considerations for these autoimmune diseases of the bile ducts.
Literatur
2.
Zurück zum Zitat Giljaca V, Gurusamy KS, Takwoingi Y, et al. (2015) Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for common bile duct stones. Cochrane Database Syst Rev 2(2):CD011549. doi:10.1002/14651858.CD011549 Giljaca V, Gurusamy KS, Takwoingi Y, et al. (2015) Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for common bile duct stones. Cochrane Database Syst Rev 2(2):CD011549. doi:10.​1002/​14651858.​CD011549
5.
Zurück zum Zitat Szary NM, Al-Kawas FH (2013) Complications of endoscopic retrograde cholangiopancreatography: how to avoid and manage them. Gastroenterol Hepatol (N Y). 9(8):496–504PubMedCentral Szary NM, Al-Kawas FH (2013) Complications of endoscopic retrograde cholangiopancreatography: how to avoid and manage them. Gastroenterol Hepatol (N Y). 9(8):496–504PubMedCentral
9.
24.
Zurück zum Zitat Ludwig J, Dickson ER, McDonald GS (1978) Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 379(2):103–112PubMedCrossRef Ludwig J, Dickson ER, McDonald GS (1978) Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 379(2):103–112PubMedCrossRef
26.
Zurück zum Zitat Navasa M, Parés A, Bruguera M, et al. (1987) Portal hypertension in primary biliary cirrhosis. Relationship with histological features. J Hepatol 5(3):292–298PubMedCrossRef Navasa M, Parés A, Bruguera M, et al. (1987) Portal hypertension in primary biliary cirrhosis. Relationship with histological features. J Hepatol 5(3):292–298PubMedCrossRef
31.
Zurück zum Zitat Corpechot C, El Naggar A, Poujol-Robert A, et al. (2006) Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 43(5):1118–1124. doi:10.1002/hep.21151 PubMedCrossRef Corpechot C, El Naggar A, Poujol-Robert A, et al. (2006) Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 43(5):1118–1124. doi:10.​1002/​hep.​21151 PubMedCrossRef
33.
Zurück zum Zitat Floreani A, Cazzagon N, Martines D, et al. (2011) Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. Dig Liver Dis 43(11):887–892. doi:10.1016/j.dld.2011.06.011 PubMed Floreani A, Cazzagon N, Martines D, et al. (2011) Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. Dig Liver Dis 43(11):887–892. doi:10.​1016/​j.​dld.​2011.​06.​011 PubMed
49.
50.
Zurück zum Zitat Melum E, Franke A, Schramm C, et al. (2011) Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet 43(1):17–19. doi:10.1038/ng.728 PubMedCrossRef Melum E, Franke A, Schramm C, et al. (2011) Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet 43(1):17–19. doi:10.​1038/​ng.​728 PubMedCrossRef
56.
Zurück zum Zitat Nakanuma Y, Harada K, Katayanagi K, Tsuneyama K, Sasaki M (1999) Definition and pathology of primary sclerosing cholangitis. J Hepatobiliary Pancreat Surg 6(4):333–342PubMedCrossRef Nakanuma Y, Harada K, Katayanagi K, Tsuneyama K, Sasaki M (1999) Definition and pathology of primary sclerosing cholangitis. J Hepatobiliary Pancreat Surg 6(4):333–342PubMedCrossRef
66.
Zurück zum Zitat Ito K, Mitchell DG, Outwater EK, Blasbalg R (1999) Primary sclerosing cholangitis: MR imaging features. AJR Am J Roentgenol 172(6):1527–1533PubMedCrossRef Ito K, Mitchell DG, Outwater EK, Blasbalg R (1999) Primary sclerosing cholangitis: MR imaging features. AJR Am J Roentgenol 172(6):1527–1533PubMedCrossRef
67.
Zurück zum Zitat Dodd GD, Baron RL, Oliver JH, Federle MP (1999) End-stage primary sclerosing cholangitis: CT findings of hepatic morphology in 36 patients. Radiology 211(2):357–362PubMedCrossRef Dodd GD, Baron RL, Oliver JH, Federle MP (1999) End-stage primary sclerosing cholangitis: CT findings of hepatic morphology in 36 patients. Radiology 211(2):357–362PubMedCrossRef
69.
70.
Zurück zum Zitat Ruiz A, Lemoinne S, Carrat F, et al. (2014) Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression. Hepatology 59(1):242–250. doi:10.1002/hep.26620 PubMedCrossRef Ruiz A, Lemoinne S, Carrat F, et al. (2014) Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression. Hepatology 59(1):242–250. doi:10.​1002/​hep.​26620 PubMedCrossRef
74.
Zurück zum Zitat Bergquist A, Glaumann H, Persson B, Broomé U (1998) Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 27(2):311–316. doi:10.1002/hep.510270201 PubMedCrossRef Bergquist A, Glaumann H, Persson B, Broomé U (1998) Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 27(2):311–316. doi:10.​1002/​hep.​510270201 PubMedCrossRef
78.
Zurück zum Zitat Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO (2002) Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 56(1):48–54. doi:10.1067/mge.2002.125367 PubMedCrossRef Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO (2002) Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 56(1):48–54. doi:10.​1067/​mge.​2002.​125367 PubMedCrossRef
79.
85.
Zurück zum Zitat Tanaka A, Tazuma S, Okazaki K, et al. (2014) Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan. J Hepatobiliary Pancreat Sci 21(1):43–50. doi:10.1002/jhbp.50 PubMedCrossRef Tanaka A, Tazuma S, Okazaki K, et al. (2014) Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan. J Hepatobiliary Pancreat Sci 21(1):43–50. doi:10.​1002/​jhbp.​50 PubMedCrossRef
86.
Zurück zum Zitat Ohara H, Nakazawa T, Kawa S, et al. (2013) Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related sclerosing cholangitis: a Japanese cohort. J Gastroenterol Hepatol 28(7):1247–1251. doi:10.1111/jgh.12248 PubMedCrossRef Ohara H, Nakazawa T, Kawa S, et al. (2013) Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related sclerosing cholangitis: a Japanese cohort. J Gastroenterol Hepatol 28(7):1247–1251. doi:10.​1111/​jgh.​12248 PubMedCrossRef
94.
Zurück zum Zitat Tokala A, Khalili K, Menezes R, Hirschfield G, Jhaveri KS (2014) Comparative MRI analysis of morphologic patterns of bile duct disease in IgG4-related systemic disease versus primary sclerosing cholangitis. Am J Roentgenol 202(3):536–543. doi:10.2214/AJR.12.10360 CrossRef Tokala A, Khalili K, Menezes R, Hirschfield G, Jhaveri KS (2014) Comparative MRI analysis of morphologic patterns of bile duct disease in IgG4-related systemic disease versus primary sclerosing cholangitis. Am J Roentgenol 202(3):536–543. doi:10.​2214/​AJR.​12.​10360 CrossRef
96.
Zurück zum Zitat Nishino T, Oyama H, Hashimoto E, et al. (2007) Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol 42(7):550–559. doi:10.1007/s00535-007-2038-8 PubMedCrossRef Nishino T, Oyama H, Hashimoto E, et al. (2007) Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol 42(7):550–559. doi:10.​1007/​s00535-007-2038-8 PubMedCrossRef
97.
Zurück zum Zitat Kim JH, Byun JH, Kim SY, et al. (2013) Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI. Acta Radiol 54(6):601–607. doi:10.1177/0284185113481018 PubMedCrossRef Kim JH, Byun JH, Kim SY, et al. (2013) Sclerosing cholangitis with autoimmune pancreatitis versus primary sclerosing cholangitis: comparison on endoscopic retrograde cholangiography, MR cholangiography, CT, and MRI. Acta Radiol 54(6):601–607. doi:10.​1177/​0284185113481018​ PubMedCrossRef
98.
Zurück zum Zitat Kim JH, Byun JH, Lee SJ, et al. (2012) Differential diagnosis of sclerosing cholangitis with autoimmune pancreatitis and periductal infiltrating cancer in the common bile duct at dynamic CT, endoscopic retrograde cholangiography and MR cholangiography. Eur Radiol 22(11):2502–2513. doi:10.1007/s00330-012-2507-1 PubMedCrossRef Kim JH, Byun JH, Lee SJ, et al. (2012) Differential diagnosis of sclerosing cholangitis with autoimmune pancreatitis and periductal infiltrating cancer in the common bile duct at dynamic CT, endoscopic retrograde cholangiography and MR cholangiography. Eur Radiol 22(11):2502–2513. doi:10.​1007/​s00330-012-2507-1 PubMedCrossRef
99.
Zurück zum Zitat Gardner CS, Bashir MR, Marin D, et al. (2015) Diagnostic performance of imaging criteria for distinguishing autoimmune cholangiopathy from primary sclerosing cholangitis and bile duct malignancy. Abdom Imaging 40(8):3052–3061. doi:10.1007/s00261-015-0543-4 PubMedCrossRef Gardner CS, Bashir MR, Marin D, et al. (2015) Diagnostic performance of imaging criteria for distinguishing autoimmune cholangiopathy from primary sclerosing cholangitis and bile duct malignancy. Abdom Imaging 40(8):3052–3061. doi:10.​1007/​s00261-015-0543-4 PubMedCrossRef
102.
Zurück zum Zitat Hoeffel C, Azizi L, Lewin M, et al. (2006) Normal and pathologic features of the postoperative biliary tract at 3D MR cholangiopancreatography and MR imaging1. Radiographics 26(6):1603–1620. doi:10.1148/rg.266055730 PubMedCrossRef Hoeffel C, Azizi L, Lewin M, et al. (2006) Normal and pathologic features of the postoperative biliary tract at 3D MR cholangiopancreatography and MR imaging1. Radiographics 26(6):1603–1620. doi:10.​1148/​rg.​266055730 PubMedCrossRef
103.
104.
Zurück zum Zitat Kim JY, Lee JM, Han JK, et al. (2007) Contrast-enhanced MRI combined with MR cholangiopancreatography for the evaluation of patients with biliary strictures: differentiation of malignant from benign bile duct strictures. J Magn Reson Imaging 26(2):304–312. doi:10.1002/jmri.20973 PubMedCrossRef Kim JY, Lee JM, Han JK, et al. (2007) Contrast-enhanced MRI combined with MR cholangiopancreatography for the evaluation of patients with biliary strictures: differentiation of malignant from benign bile duct strictures. J Magn Reson Imaging 26(2):304–312. doi:10.​1002/​jmri.​20973 PubMedCrossRef
106.
Zurück zum Zitat Abdalian R, Dhar P, Jhaveri K, et al. (2008) Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging. Hepatology 47(3):949–957. doi:10.1002/hep.22073 PubMedCrossRef Abdalian R, Dhar P, Jhaveri K, et al. (2008) Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging. Hepatology 47(3):949–957. doi:10.​1002/​hep.​22073 PubMedCrossRef
Metadaten
Titel
Imaging of autoimmune biliary disease
verfasst von
Melinda J. Yeh
So Yeon Kim
Kartik S. Jhaveri
Spencer C. Behr
Nieun Seo
Benjamin M. Yeh
Publikationsdatum
17.09.2016
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 1/2017
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0903-8

Weitere Artikel der Ausgabe 1/2017

Abdominal Radiology 1/2017 Zur Ausgabe

Classics in Abdominal Imaging

The Mercedes-Benz sign

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.